BlueRock Therapeutics is an engineered cell therapy company dedicated to developing regenerative medicines for intractable diseases. Utilizing a cell+gene platform that recapitulates developmental biology, the company creates authentic and functional cell therapies for neurology, cardiology, and immunology. BlueRock is distinguished by its scientific innovation, ethical standards, and commitment to empowering talent to advance regenerative medicine.
The Associate Director, Regulatory Affairs - CMC is responsible for providing regulatory leadership and guidance to CMC teams developing cell and gene therapy products, including the oversight and generation of quality dossiers to support Health Authority meetings, clinical trial applications and market applications in the U.S. and multiple international territories.
BlueRock Therapeutics is an engineered cell therapy company dedicated to developing regenerative medicines for intractable diseases. Utilizing a cell+gene platform that recapitulates developmental biology, the company creates authentic and functional cell therapies for neurology, cardiology, and immunology. BlueRock is distinguished by its scientific innovation, ethical standards, and commitment to empowering talent to advance regenerative medicine.
Dianthus Therapeutics, Inc.